Introduction
The First Asia-Pacifi c Gastric Cancer Conference was held on November [20] [21] [22] 2006 , at the Clinical Research Centre, National University of Singapore (NUS). The aim of this conference was to provide a platform for surgeons, gastroenterologists, oncologists, primary healthcare physicians, and scientists in the region to share their experiences in gastric cancer treatment and research. The conference was very comprehensive: it consisted of four symposia, three hands-on workshops, live demonstrations, plenary lectures, a teleconference, and poster presentations. A total of 206 international delegates from 18 countries participated in this conference, and 26 poster presentations were displayed during the conference.
First day. November 20, 2006
The conference was offi cially opened by Jimmy So (Department This symposium generated much interest among the members of the audience. Five speakers from tertiary centers throughout the region discussed their experience in the diagnosis and treatment of early gastric cancer. Priyanti Kumarasinghe, a pathologist from the NUS, compared and contrasted the Japanese and Western defi nitions of early gastric cancer. The incidence of early gastric cancer was noted to be higher in countries where asymptomatic patients are screened (16%-24% in the west and 30%-50% in Japan). She also highlighted how the differences in criteria for the diagnosis of adenocarcinoma between the two settings led to major disparities between both the incidence and the outcome of treatment of high-grade dysplasia and early gastric cancer. Then Kenjiro Yasuda, from the Kyoto Second Red Cross Hospital, Japan, described current and state-of-the-art endoscopic techniques in the diagnosis of early gastric cancer. Philip Chiu, from the Chinese University of Hong Kong, discussed advances in endoscopic imaging technology which can potentially enhance the detection and recognition of early gastric cancer. These promising new technologies, such as narrow band imaging, autofl uorescence imaging, and confocal endoscopy, may transform the management of early gastric cancer to a one-stage endoscopic procedure [5] . Ichiro Oda, from National Cancer Center Hospital, Japan, described current techniques for endo scopic mucosal resection (EMR) in the treatment of early gastric cancer, encompassing the indications and results of EMR [6] . Lastly, Enders Ng presented his center's experience with endoscopic submucosal dissection (ESD).
Plenary lecture 1. Adenocarcinoma of Gastroesophageal Junction (Chaired by Thiow Kong Ti, NUS, Singapore)
Takeshi Sano, from the National Cancer Center Hospital, Tokyo, delivered a very concise yet comprehensive review of the epidemiology, classifi cation, and treatment strategies for gastroesophageal junction carcinomas. He highlighted a recent randomized controlled trial from Japan, which suggests that Siewert type II tumors should be treated through an extended total gastrectomy via an abdominal approach [7] . A left thoracoabdominal approach confers no survival benefi t and increases the surgical morbidity.
Live demonstration. D2 Gastrectomy (Surgeon, Takeshi Sano, National Cancer Center Hospital, Tokyo, Japan)
Many surgeons in the audience were keen to observe this live demonstration of D2 subtotal gastrectomy with Roux-en-Y gastrojejunostomy for distal gastric cancer, performed by Takeshi Sano, an expert surgeon in gastric cancer. The surgery was fi lmed and transmitted live from the NUH operating theaters to the audience in the auditorium at the NUS. The participants were able to observe clearly the D2 dissection performed by Takeshi Sano. There was a lively discussion between the surgeon in the operating theater and participants in the auditorium. The live surgery took just over 2 hours, demonstrating the high skill and expertise of Takeshi Sano.
Second day. November 21, 2006
Plenary lecture 2. Chemotherapy for Advanced Gastric Cancer (Chaired by Robert Lim, NUH, Singapore)
Yoon Koo Kang, Ulsan University, Seoul, opened the second-day proceedings with a discussion that focused on chemotherapy agents for advanced gastric cancer. Continuous infusion of 5-fl uorouracil (5-FU) plus cisplatin-based combination chemotherapy has been the standard for a long time. However, oral fl uoropyrimidines, such as capecitabine (and S-1) may now be replacing infusional 5-FU in terms of effi cacy, safety, and convenience [8] .
Symposium 3. Surgery for Gastric Cancer (Chaired by
Takeshi Sano, Japan, and Wai-Keong Wong, Singapore General Hospital, Singapore)
In this symposium, fi ve topics were presented. Sudhakar Venkatesh, from the NUH, presented on imaging techniques for preoperative staging. He focused on the important role of multislide computed tomography (CT) scans in preoperative staging. Next, Chew-Wun Wu, from Taipei Veterans General Hospital, presented the results of a randomized controlled trial conducted at his institution, comparing D1 vs D3 lymph node dissection for the treatment of gastric cancer [9] . This remains the only clinical trial that has shown a survival benefi t for extended lymphadenectomy in gastric cancer surgery. Then Han-Kwang Yang, from Seoul National University Hospital, discussed the role of sentinel node biopsy in gastric cancer surgery. Sentinel node biopsy for gastric cancer, using indocyanine green, can be performed rapidly and easily, with a high detection rate. It can predict lymph node status in T1 gastric cancer with a high degree of accuracy [10] . He also described their experience with laparoscopy-assisted distal gastrectomy for early gastric cancer, reporting an advantage for the laparoscopic approach, in terms of postoperative recovery, compared to open surgery. Kent Man Chu, from Hong Kong University Hospital, spoke about surgery for locally advanced gastric cancer [11] . He described the importance of accurate preoperative staging, the extent of resection, and the role of adjuvant chemotherapy in relation to survival benefi t. He also high-lighted that risk-adjusted mortality is substantially lower when the surgery is performed by subspecialty interested and trained surgeons.
Symposium 4. Current and Future in Chemotherapy
and Radiotherapy (Chaired by Wen-Hsin Koo, National Cancer Centre, Singapore, and Robert Lim, NUH, Singapore)
Takeshi Sano began the symposium by delivering a lecture on adjuvant and neoadjuvant therapy for gastric cancer. He reviewed the literature on multimodal therapy and discussed the Japanese experience with newer agents such as S1. Next, Hans Chung, from the NUH, talked about the role of radiotherapy in adjuvant treatment for gastric cancer [12] . He highlighted a Korean study regarding the advantages of adjuvant chemoradiation after a D2 nodal dissection. The last speaker, Kian-Fong Foo, from the National Cancer Centre Singapore, reviewed current therapeutic strategies for gastrointestinal stromal tumor (GIST). He described the role of imatinib, a highly selective tyrosine kinase inhibitor, in GIST. A phase III trial of sunitinib in imatinib-resistant/-intolerant GIST showed that sunitinib was active for GIST patients who were resistant or intolerant to imatinib, and these patients showed a signifi cant improvement in time to progression after being treated with sunitinib.
Lunch satellite symposium. The Role of Xeloda (Capecitabine) for Gastric Cancer (Chaired by WeiPeng Yong, NUH, Singapore)
For this special symposium, Yoon Koo Kang, from Ulsan University, Seoul, discussed the role of Xeloda as an effective alternative replacing infusional 5-FU in advanced gastric cancer. He highlighted a few trials that favored Xeloda combination chemotherapy as fi rst-line treatment in patients with advanced gastric cancer, and noted the correlation of the Xeloda combination chemotherapy to complete response, overall survival, and safety profi les compared to other conventional regimens.
Teleconference. (Chaired by Jimmy So and Davide Lomanto, NUH, Singapore)
This live teleconference session (Fig. 1) involved centers from four different countries: Korea, Japan, Taiwan, and Singapore. The fi rst session was transmitted from Korea, where Hyung-Ho Kim (Seoul National University Bundang Hospital, Korea) spoke about the role of laparoscopy-assisted radical gastrectomy. Next, Kazuhiko Nakamura (Kyushu University Hospital, Japan) discussed ESD for the treatment of early gastric cancer. Ming-Tsan Lin (National Taiwan University Hospital) then showed us a video demonstration of his novel technique of gasless laparoscopy-assisted radical gastrectomy. A lively debate ensued about the relative advantages of the different laparoscopyassisted techniques.
Live demonstration A. Laparoscopic Gastrectomy:
Live Surgery from Korea (Chaired by Simon Wong, Pamela Youde, Nethersole Eastern Hospital, Hong Kong, Hong Kong, and Khong-Hee Lim, Tan Tock Seng Hospital, Singapore, and Hock-Soo Ong, Singapore General Hospital, Singapore)
In this live session from Korea, Hyung-Ho Kim demonstrated his technique for laparoscopy-assisted radical gastrectomy. The audience was impressed by his skill in performing this technically challenging procedure.
Live demonstration B. Endoscopic Submucosal Dissection (ESD) and Endoscopic Ultrasound (EUS) (Chaired by Lawrence Ho and Christopher Khor, NUH, Singapore)
This was a live session demonstrating the ESD technique for early gastric cancer. Two patients with early gastric cancer had ESD performed by Ichiro Oda, from the National Cancer Centre, Tokyo, and EUS was performed in three patients by Kenjiro Yasuda, Japan, and John Meenan, United Kingdom.
Third Day, November 22, 2006
Three workshops were held concurrently, and each workshop was conducted by distinguished overseas faculty together with local experts from Singapore to share their experiences and discuss current issues. Participants had the opportunity to practice new techniques in hands-on sessions during these workshops. The workshop started with a series of lectures and video demonstrations in the morning. Kent-Man Chu started off with his lecture on the surgical anatomy of the stomach. This was followed by a lecture from Takeshi Sano, who presented on the current Japanese classifi cation of gastric cancer and contrasted it with other staging systems [13] . The third speaker, Chew-Wun Wu, was very persuasive with his lecture entitled "Why do D2 gastrectomy?". He presented data from his randomized controlled trial comparing D1 vs D3 gastrectomy. Han-Kwang Yang and Takeshi Sano both showed us videos demonstrating the D2 gastrectomy technique. Participants then proceeded to the hands-on cadaveric dissection session (Fig. 2) . A faculty member was assigned to each group, overseeing the cadaver as the moderator. Participants (Fig. 3) were given the opportunity to perform subtotal gastrectomy and D2 lymph node dissection with step-by-step instructions. The program began with a short introduction and lecture on the techniques of ESD by Ichiro Oda. Then participants were given the opportunity to perform ESD on a live pig model. Next, Ichiro Oda showed a video on managing diffi cult situations in ESD. Philip Chiu discussed the management of complications and post-ESD care.
Workshop B. Endoscopic Submucosal Dissection (ESD) for Early Gastric

Workshop C. ASEAN Hands-on Basic EUS Workshop
This was held in conjunction with the Annual ASEAN EUS Forum 2006. The workshop, which consisted of lectures, video demonstrations, and a hands-on session with live animals, covered both the diagnostic and therapeutic uses of EUS.
Conclusion
The fi rst Asia-Pacifi c Gastric Cancer Conference ended successfully on November 23, 2006. We feel that this conference provided an excellent opportunity in this region for physicians and research scientists to learn from one another and perhaps to collaborate on future research projects. We hope to meet our friends and colleagues at future Asia-Pacifi c Gastric Cancer Conferences. 
